Veterinary Medicines

PESTORIN MORMYX

Authorised
  • Myxoma virus, strain CAMP V-219, Live
  • Rabbit haemorrhagic disease virus, strain CAMP-V351, Inactivated
Download as PDF

Product identification

Medicine name:
PESTORIN MORMYX
Active substance:
  • Myxoma virus, strain CAMP V-219, Live
  • Rabbit haemorrhagic disease virus, strain CAMP-V351, Inactivated
Target species:
  • Rabbit
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Myxoma virus, strain CAMP V-219, Live
    3.30
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Rabbit haemorrhagic disease virus, strain CAMP-V351, Inactivated
    7.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AH01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120311
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 20/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."